View Post

All Patients With Metastatic Breast Cancer Should Undergo Germline Testing, Study Finds

In In The News by Barbara Jacoby

By: Laura Joszt From: ajmc.com All patients with metastatic breast cancer should undergo genetic testing, according to a new study on the prevalence of pathogenic/likely pathogenic (P/LP) variants in patients with metastatic breast cancer. The results, published in JAMA Oncology, highlight that there is a high prevalence of P/LP variants among the group of patients with metastatic breast cancer, which could have …

View Post

What Influence Do Treatment Costs Have on Breast Cancer Surgery Preferences?

In In The News by Barbara Jacoby

By: Christina Bennett, MS From: cancernetwork.com When deciding about surgery for breast cancer, women, especially those with a lower household income, factored cost of treatment into their decision, according to a study reported in the Journal of Oncology Practice. Julie Nangia, MD, an assistant professor of medicine at the Lester and Sue Breast Center at Baylor College of Medicine, Houston, …

View Post

Fewer lymph node operations for breast cancer patients with new prediction models

In In The News by Barbara Jacoby

By: Lund University From: medicalxpress.com In recently published studies, researchers at Lund University and Skåne University Hospital in Sweden have produced new prediction models for improved personalized treatment of lymph nodes in breast cancer patients. The latest results that have now been published in Clinical Cancer Research and BMC Cancer show that up to one in every three operations could …

View Post

20% of women getting lumpectomies need a second surgery, but this risk can be lowered

In In The News by Barbara Jacoby

By: Sheldon Feldman, M.D., F.A.C.S. From: sharsheret.org The lumpectomy procedure (sometimes referred to as Breast Conserving Surgery, or BCS) is the treatment of choice for many people with early-stage breast cancer. The surgeon seeks to remove the malignant tumor, while leaving behind as much healthy breast tissue as possible.   Studies show that this procedure, when coupled with radiation, is …

View Post

In first, cancer drugs simultaneously approved in US, Canada, Australia

In In The News by Barbara Jacoby

From: biopharmadive.com For the first time, regulators in the U.S., Australia and Canada on Tuesday simultaneously approved two cancer drugs via a project led by the Food and Drug Administration’s oncology center. Merck & Co.’s immunotherapy Keytruda, when paired with Merck and Eisai’s Lenvima, is now cleared to treat certain endometrial tumors, a decision that expands the labels for both …

View Post

Cancer cells turn to cannibalism to survive chemotherapy, study suggests

In In The News by Barbara Jacoby

By: Rockefeller University Press From: medicalxpress.com Researchers from the Tulane University School of Medicine have discovered that some cancer cells survive chemotherapy by eating their neighboring tumor cells. The study, which will be published September 17 in the Journal of Cell Biology, suggests that this act of cannibalism provides these cancer cells with the energy they need to stay alive …

View Post

Proton Therapy Coming to Kansas City with Opening of Provision CARES Proton Therapy Center

In In The News by Barbara Jacoby

Source: Provision Solutions From: PR Newswire Provision Healthcare announces the expansion of the Provision CARES Cancer Network with plans to develop the Provision CARES Cancer Center and Proton Therapy Center in Kansas City, KS. The center will be the first to open in Kansas, located in the Lenexa community of Kansas City to serve patients in the area and surrounding region …

View Post

AI can predict the chances of surviving oral cancer

In In The News by Barbara Jacoby

From: University of Warwick State-of-the-art AI algorithms applied to digitised images of oral cancer tissue specimens can be used to predict their chances of survival by measuring the abundance of Tumour infiltrating immune cells Tumour infiltrating lymphocytes (a specific type of immune cells) are key in determining how oral cancers spread and react to treatments University of Warwick researchers were …

View Post

Savvy Cooperative: Paid Opportunity to Help Co-create a Mobile App for Prostate Cancer Patients

In In The News by Barbara Jacoby

Description: A health innovation team is developing a mobile app for patients with prostate cancer to help facilitate treatments and enhance the quality of life. They know how critical it is to hear directly from patients while they are in the ideation and development stage.   The team would like to conduct a 30-minute phone interview with selected applicants between November …

View Post

Breast Cancer Drugs May Severely Inflame Lungs, FDA Warns

In In The News by Barbara Jacoby

From: Nick Mulcahy From: medscape.com The US Food and Drug Administration (FDA) issued a warning today that the commonly prescribed breast cancer therapies known as cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors may cause rare but severe inflammation of the lungs. The related products include palbociclib (Ibrance, Pfizer), ribociclib (Kisqali, Novartis), and abemaciclib (Verzenio, Eli Lilly), which are approved for use …